Mirae Asset Global ETFs Holdings
PLRX icon

Mirae Asset Global ETFs Holdings’s Pliant Therapeutics PLRX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-33,923
Closed -$45.8K – 3180
2025
Q1 		$45.8K Buy
33,923
+1,492
+5% +$9.06K ﹤0.01% 2865
2024
Q4 		$427K Buy
32,431
+1,141
+4% +$15.6K ﹤0.01% 1999
2024
Q3 		$351K Buy
31,290
+2,004
+7% +$25.1K ﹤0.01% 2091
2024
Q2 		$315K Buy
+29,286
New +$378K ﹤0.01% 2044

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PLRX Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 33,923 shares — an estimated $45.8K sold.

Mirae Asset Global ETFs Holdings first reported a position in PLRX in Q2 2024 and held it in 4 quarters. The position peaked at $427K in Q4 2024. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 33,923 Pliant Therapeutics shares in Q2 2025, an estimated $45.8K.
  • Mirae Asset Global ETFs Holdings first reported a position in Pliant Therapeutics in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Pliant Therapeutics position peaked at $427K in Q4 2024.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.